Evidence map›Paper›PMID 39255385›Full record

ArticleAnalytical chemistry2024

Analysis of the Structure of 14 Therapeutic Antibodies Using Circular Dichroism Spectroscopy.

Maria G Bruque, Alison Rodger, Søren Vrønning Hoffmann, Nykola C Jones, Jean Aucamp, Tim R Dafforn, Owen R T Thomas

Abstract read
In one paragraph

Article in Analytical chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maria G BruqueSchool of Chemical Engineering, University of Birmingham, Edgbaston B15 2TT, U.K.
Alison RodgerResearch School of Chemistry, The Australian National University, Canberra 2601, Australia.ORCID 0000-0002-7111-3024
Søren Vrønning HoffmannISA,Department of Physics and Astronomy, Aarhus University, Aarhus 8000, Denmark.ORCID 0000-0002-8018-5433
Nykola C JonesISA,Department of Physics and Astronomy, Aarhus University, Aarhus 8000, Denmark.ORCID 0000-0002-4081-6405
Jean AucampLonza Biologics, Slough SL1 4DX, U.K.
Tim R DaffornSchool of Biosciences, University of Birmingham, Edgbaston B15 2TT, U.K.
Owen R T ThomasSchool of Chemical Engineering, University of Birmingham, Edgbaston B15 2TT, U.K.ORCID 0000-0001-8253-365X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding the impact of the manufacturing environment on therapeutic monoclonal antibody (mAb) structures requires new process analytical technology. Here, we describe the creation of a new reference set for the circular dichroism (CD) spectra of mAbs. Data sets of the highest quality were collected by synchrotron radiation CD for 14 different mAbs in both native and acid-stressed states. Deconvolution of far-UV spectra for the mAb cohort identified two current reference sets (SP175 and SMP180) as assigning accurate secondary structures, irrespective of the analysis program employed. Scrutiny of spectra revealed significant variation in the far-UV and especially near-UV CD of the 14 mAbs. Two spectral features were found to be sensitive to changes in solution pH, i.e., the far-UV positive peak at 201-202 nm and the near-UV negative exciton couplet around 230-240 nm. The latter feature offers attractive possibilities for in-line CD-based monitoring of the mAb structure during manufacture.

Identifiers

PMID39255385
PMCPMC11428090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.